BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:GZR33 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of GZR33\, from ClinicalTrials.gov estimates
 .
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07918898-444@assetmemo.bio
DTSTAMP:20261121T005909Z
DTSTART;VALUE=DATE:20270202
DTEND;VALUE=DATE:20270203
SUMMARY:GZR33: Phase 1 readout est. (NCT07918898)
DESCRIPTION:GZR33\, phase 1.\nStudy: Comparison of Pharmacokinetic/Pharmaco
 dynamic Characteristics and Safety of GZR101-80 Injection With Separately 
 Injected\, Simultaneous Doses of GZR33 Injection and Insulin Aspart\nEstim
 ated primary completion: 2 February 2027. This is a ClinicalTrials.gov est
 imate\, not a confirmed readout date\, and it can move.\nDrug page: https:
 //assetmemo.bio/drug/gzr33#upcoming-events\nRegistry record: https://clini
 caltrials.gov/study/NCT07918898
URL:https://assetmemo.bio/drug/gzr33#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
